Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Phospho-EGF Receptor (Tyr1045) Antibody (3A670) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1045). Anti-Phospho-EGF Receptor (Tyr1045) Antibody (3A670) can be used in WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 20 μL | $81 | 7-10 days | 7-10 days | |
| 100 μL | $233 | 7-10 days | 7-10 days |
| Description | Anti-Phospho-EGF Receptor (Tyr1045) Antibody (3A670) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1045). Anti-Phospho-EGF Receptor (Tyr1045) Antibody (3A670) can be used in WB. |
| Synonyms | PIG61, Phospho-EGF Receptor (Y1045), p-EGF Receptor (Y1045), p-EGF Receptor (Tyr1045), NISBD2, mENA, HER-1, HER1, ERRP, ERBB-1, ERBB1, ERBB, EGF Receptor (p-Y1045), EGF Receptor (p-Tyr1045) |
| Ig Type | Rabbit IgG |
| Clone | 3A670 |
| Reactivity | Human |
| Specificity | Human Phospho-EGF Receptor (Tyr1045), which correspond to Phospho-EGF Receptor (Tyr1069) of P00533-1 in UniProt. |
| Verified Activity | Western blot analysis of extracts from serum-starved Hela, untreated (-) or treated with EGF (100 ng/mL, 10min) using Phospho-EGF Receptor (Tyr1045) rabbit monoclonal Antibody at 1:1000 dilution (upper) or anti-EGFR antibody (lower). |
| Application | |
| Recommended Dose | WB: 1:1000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with a synthetic phosphopeptide corresponding to residues around Tyr1045 of the Human Phospho-EGF Receptor. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | A synthetic peptide: residues around Tyr1045 of the Human Phospho-EGF Receptor |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.